This episode discusses CAR T-cell therapy and its impact on personalized cancer treatment with experts from Oregon Health & Science University.
CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families. In this episode, we speak with Dr. Richard Maziarz and CAR T Nurse Coordinator Bashi Ratterree of Oregon Health & Science University (OHSU). Together, they explain how CAR T‑cell therapy works, who may be eligible, what patients can expect during treatment and recovery, and the promising advancements shaping the future of this innovative therapy. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: CAR T-cell therapy Clinical Trial Support Center CAR T-Cell Therapy: A Path of Hope and Healing Video Series Bloodline Breakthroughs: innovations and inspiration video podcast: CAR T-cell Therapy Hem atology Horizons vlog: CAR T-Cell Therapy and the Patient Experience CAR T-Cell Therapy: Side Effects video Additional Blood Cancer United Support Resources: Information Specialists Financial support Online Chat Free Nutrition Consultations Free telephone/web patient programs Free booklets Young Adult Resources Support groups Caregiver support Caregiver…
Guests: Dr. Richard Maziarz, Bashi Ratterree
Bristol Myers Squibb, Johnson & Johnson, Legend Biotech, Kite, a Gilead Company, Novartis Pharmaceuticals Corporation
Organizations: Oregon Health & Science University
Explore listener stats, chart rankings, contacts and more on the The Bloodline with Blood Cancer United Podcast podcast page.